Loading…
Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β-lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosoma...
Saved in:
Published in: | Brazilian journal of microbiology 2014-07, Vol.45 (3), p.791-798 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c484t-b507af6ae780986ebcc508d8f7b5932a4024d0e88e4e7a3cb3ae514c63e306733 |
---|---|
cites | |
container_end_page | 798 |
container_issue | 3 |
container_start_page | 791 |
container_title | Brazilian journal of microbiology |
container_volume | 45 |
creator | Yusuf, I Arzai, A H Haruna, M Sharif, A A Getso, M I |
description | Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β-lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β-lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics. |
doi_str_mv | 10.1590/S1517-83822014000300005 |
format | article |
fullrecord | <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S1517_83822014000300005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1517_83822014000300005</scielo_id><sourcerecordid>1634273113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-b507af6ae780986ebcc508d8f7b5932a4024d0e88e4e7a3cb3ae514c63e306733</originalsourceid><addsrcrecordid>eNp9UU2LFDEQDaK46-pf0IAXD_Za-eqkL4Ksn7joQUXwEtKZ6pkM3Z3ZJC347804u4Mf4CGkSN579V4VIY8YnDPVwbNPTDHdGGE4ByYBQNQD6hY5Za02jZSgbtf6BnRC7uW8BeAKJL9LTriSWnfQnZJvL7GgLyHONA50WsYS6Cota5owh1zcXGjvfMEUHA0zndw2JrqJeReKG_P-6b2b41P6Iaayab5iLrUO6z3-PrkzVAw-uL7PyJfXrz5fvG0uP755d_HisvHSyNL0CrQbWofaQGda7L1XYFZm0L3qBHcSuFwBGoMStRO-Fw4Vk74VKKDVQpyR84Nu9gHHaLdxSXNtaH8Nyf4zpEp4fiDsln7Clce5JDfaXQqTSz9sdMH--TOHjV3H71ZykF0LVeDJtUCKV0vNbKeQPY6jmzEu2bJWSK4FY3tzj_-CHu2xttPcdKBNRekDyqeYc8LhaIaB3S_8P1ke_p7lyLvZsPgJtT6jrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1697289078</pqid></control><display><type>article</type><title>Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria</title><source>SciELO</source><source>PubMed Central</source><creator>Yusuf, I ; Arzai, A H ; Haruna, M ; Sharif, A A ; Getso, M I</creator><creatorcontrib>Yusuf, I ; Arzai, A H ; Haruna, M ; Sharif, A A ; Getso, M I</creatorcontrib><description>Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β-lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β-lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.</description><identifier>ISSN: 1517-8382</identifier><identifier>ISSN: 1678-4405</identifier><identifier>EISSN: 1678-4405</identifier><identifier>DOI: 10.1590/S1517-83822014000300005</identifier><identifier>PMID: 25477909</identifier><language>eng</language><publisher>Brazil: Springer Nature B.V</publisher><subject>Bacteria ; Bacterial Proteins - genetics ; Bacterial Proteins - metabolism ; beta-Lactamases - genetics ; beta-Lactamases - metabolism ; Drug resistance ; Drug Resistance, Multiple, Bacterial ; Gram-Negative Bacteria - drug effects ; Gram-Negative Bacteria - enzymology ; Gram-Negative Bacteria - genetics ; Gram-Negative Bacteria - isolation & purification ; Gram-Negative Bacterial Infections - microbiology ; Hospitals ; Microbial Sensitivity Tests ; MICROBIOLOGY ; Nigeria ; Plasmids - analysis ; Research Paper</subject><ispartof>Brazilian journal of microbiology, 2014-07, Vol.45 (3), p.791-798</ispartof><rights>Copyright Sociedade Brasileira de Microbiologia 2014</rights><rights>Copyright © 2014, Sociedade Brasileira de Microbiologia 2014</rights><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-b507af6ae780986ebcc508d8f7b5932a4024d0e88e4e7a3cb3ae514c63e306733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204960/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204960/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,24149,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25477909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yusuf, I</creatorcontrib><creatorcontrib>Arzai, A H</creatorcontrib><creatorcontrib>Haruna, M</creatorcontrib><creatorcontrib>Sharif, A A</creatorcontrib><creatorcontrib>Getso, M I</creatorcontrib><title>Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria</title><title>Brazilian journal of microbiology</title><addtitle>Braz J Microbiol</addtitle><description>Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β-lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β-lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.</description><subject>Bacteria</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - metabolism</subject><subject>beta-Lactamases - genetics</subject><subject>beta-Lactamases - metabolism</subject><subject>Drug resistance</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Gram-Negative Bacteria - drug effects</subject><subject>Gram-Negative Bacteria - enzymology</subject><subject>Gram-Negative Bacteria - genetics</subject><subject>Gram-Negative Bacteria - isolation & purification</subject><subject>Gram-Negative Bacterial Infections - microbiology</subject><subject>Hospitals</subject><subject>Microbial Sensitivity Tests</subject><subject>MICROBIOLOGY</subject><subject>Nigeria</subject><subject>Plasmids - analysis</subject><subject>Research Paper</subject><issn>1517-8382</issn><issn>1678-4405</issn><issn>1678-4405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UU2LFDEQDaK46-pf0IAXD_Za-eqkL4Ksn7joQUXwEtKZ6pkM3Z3ZJC347804u4Mf4CGkSN579V4VIY8YnDPVwbNPTDHdGGE4ByYBQNQD6hY5Za02jZSgbtf6BnRC7uW8BeAKJL9LTriSWnfQnZJvL7GgLyHONA50WsYS6Cota5owh1zcXGjvfMEUHA0zndw2JrqJeReKG_P-6b2b41P6Iaayab5iLrUO6z3-PrkzVAw-uL7PyJfXrz5fvG0uP755d_HisvHSyNL0CrQbWofaQGda7L1XYFZm0L3qBHcSuFwBGoMStRO-Fw4Vk74VKKDVQpyR84Nu9gHHaLdxSXNtaH8Nyf4zpEp4fiDsln7Clce5JDfaXQqTSz9sdMH--TOHjV3H71ZykF0LVeDJtUCKV0vNbKeQPY6jmzEu2bJWSK4FY3tzj_-CHu2xttPcdKBNRekDyqeYc8LhaIaB3S_8P1ke_p7lyLvZsPgJtT6jrQ</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Yusuf, I</creator><creator>Arzai, A H</creator><creator>Haruna, M</creator><creator>Sharif, A A</creator><creator>Getso, M I</creator><general>Springer Nature B.V</general><general>Sociedade Brasileira de Microbiologia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CLZPN</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>GPN</scope></search><sort><creationdate>20140701</creationdate><title>Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria</title><author>Yusuf, I ; Arzai, A H ; Haruna, M ; Sharif, A A ; Getso, M I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-b507af6ae780986ebcc508d8f7b5932a4024d0e88e4e7a3cb3ae514c63e306733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Bacteria</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - metabolism</topic><topic>beta-Lactamases - genetics</topic><topic>beta-Lactamases - metabolism</topic><topic>Drug resistance</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Gram-Negative Bacteria - drug effects</topic><topic>Gram-Negative Bacteria - enzymology</topic><topic>Gram-Negative Bacteria - genetics</topic><topic>Gram-Negative Bacteria - isolation & purification</topic><topic>Gram-Negative Bacterial Infections - microbiology</topic><topic>Hospitals</topic><topic>Microbial Sensitivity Tests</topic><topic>MICROBIOLOGY</topic><topic>Nigeria</topic><topic>Plasmids - analysis</topic><topic>Research Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yusuf, I</creatorcontrib><creatorcontrib>Arzai, A H</creatorcontrib><creatorcontrib>Haruna, M</creatorcontrib><creatorcontrib>Sharif, A A</creatorcontrib><creatorcontrib>Getso, M I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Latin America & Iberia Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><jtitle>Brazilian journal of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yusuf, I</au><au>Arzai, A H</au><au>Haruna, M</au><au>Sharif, A A</au><au>Getso, M I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria</atitle><jtitle>Brazilian journal of microbiology</jtitle><addtitle>Braz J Microbiol</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>45</volume><issue>3</issue><spage>791</spage><epage>798</epage><pages>791-798</pages><issn>1517-8382</issn><issn>1678-4405</issn><eissn>1678-4405</eissn><abstract>Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β-lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β-lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.</abstract><cop>Brazil</cop><pub>Springer Nature B.V</pub><pmid>25477909</pmid><doi>10.1590/S1517-83822014000300005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1517-8382 |
ispartof | Brazilian journal of microbiology, 2014-07, Vol.45 (3), p.791-798 |
issn | 1517-8382 1678-4405 1678-4405 |
language | eng |
recordid | cdi_scielo_journals_S1517_83822014000300005 |
source | SciELO; PubMed Central |
subjects | Bacteria Bacterial Proteins - genetics Bacterial Proteins - metabolism beta-Lactamases - genetics beta-Lactamases - metabolism Drug resistance Drug Resistance, Multiple, Bacterial Gram-Negative Bacteria - drug effects Gram-Negative Bacteria - enzymology Gram-Negative Bacteria - genetics Gram-Negative Bacteria - isolation & purification Gram-Negative Bacterial Infections - microbiology Hospitals Microbial Sensitivity Tests MICROBIOLOGY Nigeria Plasmids - analysis Research Paper |
title | Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A17%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20multi%20drug%20resistant%20bacteria%20in%20major%20hospitals%20in%20Kano,%20North-West,%20Nigeria&rft.jtitle=Brazilian%20journal%20of%20microbiology&rft.au=Yusuf,%20I&rft.date=2014-07-01&rft.volume=45&rft.issue=3&rft.spage=791&rft.epage=798&rft.pages=791-798&rft.issn=1517-8382&rft.eissn=1678-4405&rft_id=info:doi/10.1590/S1517-83822014000300005&rft_dat=%3Cproquest_sciel%3E1634273113%3C/proquest_sciel%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-b507af6ae780986ebcc508d8f7b5932a4024d0e88e4e7a3cb3ae514c63e306733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1697289078&rft_id=info:pmid/25477909&rft_scielo_id=S1517_83822014000300005&rfr_iscdi=true |